TSLA
Tesla
-- 248.710 NVDA
NVIDIA
-- 117.700 MU
Micron Technology
-- 94.720 NKE
Nike
-- 67.940 PLTR
Palantir
-- 90.960 
NEWS
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting
Biora Therapeutics (Nasdaq: BIOR) announced that CEO Adi Mohanty will present the company's new 00-size BioJet™ device at the 14th Annual Partnership Opportunities in Drug Delivery (PODD) meeting in Boston, October 28–29, 2024. The company has successfully reduced the device size from 000 to 00 while increasing payload capacity, aligning with strong patient and pharma collaborator preferences.
Mohanty emphasized the significance of this development, describing it as a revolutionary, needleless, liquid injection technology in a smaller, patient-friendly capsule. The presentation, titled 'Solving Drug Delivery Challenges with Ingestible Drug-Device Combinations,' is scheduled for October 28, 2024, at 3:30 PM Eastern Time in the Westin Boston Seaport.
The PODD meeting provides Biora Therapeutics an opportunity to update on their BioJet and NaviCap platforms and engage with existing pharma collaborators as they seek to expand these relationships.
Mohanty emphasized the significance of this development, describing it as a revolutionary, needleless, liquid injection technology in a smaller, patient-friendly capsule. The presentation, titled 'Solving Drug Delivery Challenges with Ingestible Drug-Device Combinations,' is scheduled for October 28, 2024, at 3:30 PM Eastern Time in the Westin Boston Seaport.
The PODD meeting provides Biora Therapeutics an opportunity to update on their BioJet and NaviCap platforms and engage with existing pharma collaborators as they seek to expand these relationships.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment